Robert Gundel

Robert Gundel

Geen lopende functies
Health Technology
Consumer Services
Finance

Profiel

Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.

Eerdere bekende functies van Robert Gundel

BedrijvenFunctieEinde
PROMIS NEUROSCIENCES, INC. Algemeen Directeur 29-06-2015
SCORPIUS HOLDINGS, INC. Hoofd Techniek/Wetenschap/O&O 01-01-2009
Hoofd Techniek/Wetenschap/O&O 01-11-2008
Hoofd Techniek/Wetenschap/O&O 01-01-2008
Corporate Officer/Principal 01-01-2007
Ervaring van Robert Gundel in detail bekijken

Opleiding van Robert Gundel

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

24

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Finance

  1. Beurs
  2. Insiders
  3. Robert Gundel
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU